Tr1X

Tr1X is a biotechnology company focused on developing novel regulatory T cell-based therapies to treat autoimmune and inflammatory diseases. The company employs advanced genetic engineering techniques combined with extensive T cell biology research to create scalable cellular therapies that aim to restore immune tolerance and prevent severe autoimmune conditions, such as Crohn’s Disease. Tr1X's therapies are designed to mimic naturally occurring Type 1 regulatory T cells, working to stabilize immune responses and halt inflammation.